CNR1 and schizophrenia: For instance, in the sub-chronic phencyclidine (PCP) rat model of schizophrenia, we previously demonstrated that social withdrawal–a core negative symptoms of schizophrenia–was associated with deficient endocannabinoid-mediated CB1 activation [33,35].